AMY2A

Pancreatic alpha-amylase · P04746 · AMY2A on Sugi Atlas →

5,969 patent compounds predicted against AMY2A, 3,770 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL7763081 SCHEMBL7763081 0.49 10/20
Acarbose Acarbose (SCHEMBL16848) 1.00 9/20
Acarbose Acarbose (SCHEMBL16849) 1.00 9/20
Acarbose Acarbose (SCHEMBL611277) 1.00 9/20
Acarbose Acarbose (SCHEMBL681337) 1.00 9/20
Acarbose Acarbose (SCHEMBL4068725) 1.00 9/20
Acarbose Acarbose (SCHEMBL4121036) 1.00 9/20
Acarbose Acarbose (SCHEMBL4121040) 1.00 9/20
SCHEMBL4313896 SCHEMBL4313896 1.00 9/20
SCHEMBL4314669 SCHEMBL4314669 1.00 9/20
SCHEMBL4321098 SCHEMBL4321098 1.00 9/20
Acarbose Acarbose (SCHEMBL5316305) 1.00 9/20
Acarbose Acarbose (SCHEMBL690901) 0.93 9/20
Acarbose Acarbose (SCHEMBL692582) 0.91 9/20
SCHEMBL5161028 SCHEMBL5161028 0.88 9/20
SCHEMBL5161010 SCHEMBL5161010 0.87 9/20
Acarbose Acarbose (SCHEMBL2320932) 0.86 9/20
Acarbose Acarbose (SCHEMBL7601414) 0.81 9/20
Acarbose Acarbose (SCHEMBL536524) 0.80 9/20
Acarbose Acarbose (SCHEMBL2345914) 0.78 9/20

Clinical trials — most relevant to AMY2A by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Confirmatory Clinical Study in NSCLC Patients With MET Exon 14 Mutation (KUNPENG-2) PHASE3RECRUITING
A Double-Blind, Placebo-Controlled Study of Fermented Deglycyrrhizinated Licorice Extract PHASE2COMPLETED
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes PHASE2RECRUITING
A Trial to Assess the Effect of Kidney Impairment on How AMG 133 is Absorbed, Broken Down, and Eliminated by the Body PHASE1COMPLETED
Acute Effect of HP-211 (Axulin) on Blood Glucose and Serum Insulin Responses in Healthy Lean and Overweight Humans PHASE1COMPLETED
Acute Pancreatitis Targets (APT) Study nanCOMPLETED
Translation and Validation of Chinese COMPAT-SF nanRECRUITING
Dexmedetomidine and Propofol in Mechanically Ventilated Patients by Using Salivary Alpha-amylase as a Stress Marker nanCOMPLETED
Utility of Trypsinogen -2 in Early Detection and Follow Up of Post-pancreatectomy Acute Pancreatitis (PPAP) nanRECRUITING
Perioperative Salivary Alpha-amylase as a Predictor of Delirium After Lower Extremity Vascular Bypass Surgery nanCOMPLETED
Effects of Seaweed Extract on Postprandial Response to White Bread nanUNKNOWN
Markers in Acute Pancreatitis-1 nanCOMPLETED
Effect of Proprietary Botanical Blend on Glycemic Control and Post-prandial Carbohydrate Absorption nanUNKNOWN
Long-term Health After Severe Acute Malnutrition in Children and Adults: the Role of the Pancreas nanCOMPLETED
Randomized Trial of Aggressive Fluid Hydration to Prevent Post ERCP Pancreatitis nanCOMPLETED
The Evaluation of Pro/Antioxidative Profile and Diagnostic Parameters in the Patients With Pancreatic Disease nanCOMPLETED
Entral Feeding in Acute Severe Pancreatitis nanCOMPLETED
Clinical and Economic Validation of the ISGPS Definition of PPAP nanCOMPLETED
Small Intestinal Bacterial Overgrowth (SIBO) in Pancreatic Adenocarcinoma (PDAC) nanRECRUITING
EUS-guided FNB-induced PANCREatitis Assessment nanRECRUITING
Early Oral Refeeding in Mild Acute Pancreatitis nanCOMPLETED
Interest of the Sialendoscopy Associated With a Local Injection of Corticosteroids in the Treatment of Radio-induced Xerostomia in Comparison With the Hygiene Rules nanUNKNOWN
A Case-control Study Comparing Glycaemic Control in Pancreatic Cancer Patients vs Healthy Matched Individuals. nanCOMPLETED
Allopurinol in Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis nanCOMPLETED
A Proof-of-Concept Study Evaluating LINFU™ nanCOMPLETED
Pancreatic Exocrine Insufficiency in Acute Pancreatitis nanCOMPLETED
Select Indian Ragas on Electrophysiological Parameters nanCOMPLETED
Tracheal Dosage of Amylase : a New Surrogate for Microaspirations in Ventilated ICU Patients nanCOMPLETED
Predicting Pancreatic Necrosis Using mitDNA nanUNKNOWN
Intramuscular Diclofenac in the Prevention of Post-ERCP Pancreatitis nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a AMY2A binder may also engage these)

ProteinNameSimilarity
P19961 1.000 P19961 →
P0DTE7 1.000 P0DTE7 →
AMY1A Alpha-amylase 1A 1.000 landscape →
P00689 1.000 P00689 →
P0DTE8 0.999 P0DTE8 →
P00688 0.997 P00688 →
P00690 0.996 P00690 →
P00687 0.995 P00687 →
P83053 0.993 P83053 →
H2N0D4 0.985 H2N0D4 →
P54215 0.971 P54215 →
Q23835 0.971 Q23835 →
P08144 0.970 P08144 →
O18345 0.970 O18345 →
Q9BN01 0.966 Q9BN01 →
P17859 0.964 P17859 →
P83833 0.964 P83833 →
P27937 0.963 P27937 →
P81641 0.963 P81641 →
P09107 0.961 P09107 →
P04063 0.960 P04063 →
P27939 0.960 P27939 →
P04747 0.956 P04747 →
P56634 0.955 P56634 →
P27934 0.954 P27934 →
P91778 0.953 P91778 →
O18552 0.953 O18552 →
O77011 0.952 O77011 →
O18420 0.951 O18420 →
O77016 0.950 O77016 →